This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
At a recent Pharmaceutical Care Management Association conference, several companies in the CNS space agreed that better biomarkers could improve drug development. From your work on the AstraMerck merger to your leadership at Alnylam, you’ve been in the biopharma industry for over 30 years. But innovation doesn’t stop in the lab.
In the realm of pharmaceuticals, where innovation can be the difference between life and death, the emergence of generative AI, has been nothing short of transformative. By harnessing the capabilities of AI, the pharmaceutical industry is unlocking novel possibilities that were once deemed unattainable.
Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; its always about people, processes, and technology. The post The AI Advantage: Reimagining the Future of Drug Development appeared first on MedCity News.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Biopharma 
52 
Let's personalize your content